应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
UNCY Unicycive Therapeutics, Inc.
休市中 04-19 16:00:00 EDT
1.07
-0.02
-1.83%
盘后
1.05
-0.02
-1.87%
18:15 EDT
最高
1.13
最低
1.04
成交量
23.10万
今开
1.10
昨收
1.09
日振幅
8.26%
总市值
3,719万
流通市值
1,470万
总股本
3,476万
成交额
25.14万
换手率
1.68%
流通股本
1,374万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Unicycive Therapeutics, Inc.盘中异动 临近午盘急速拉升8.84%
自选股智能写手 · 03-25
Unicycive Therapeutics, Inc.盘中异动 临近午盘急速拉升8.84%
Unicycive Therapeutics, Inc.盘中异动 早盘急速拉升10.79%
自选股智能写手 · 03-14
Unicycive Therapeutics, Inc.盘中异动 早盘急速拉升10.79%
Unicycive Therapeutics, Inc.盘中异动 早盘股价大跌5.50%
自选股智能写手 · 03-04
Unicycive Therapeutics, Inc.盘中异动 早盘股价大跌5.50%
Unicycive Therapeutics Inc盘中异动 急速下跌5.33%
自选股智能写手 · 02-28
Unicycive Therapeutics Inc盘中异动 急速下跌5.33%
Unicycive Therapeutics Inc盘中异动 股价大跌5.85%
自选股智能写手 · 02-26
Unicycive Therapeutics Inc盘中异动 股价大跌5.85%
加载更多
公司概况
公司名称:
Unicycive Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。
发行价格:
--
{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":1.07,"timestamp":1713556800000,"preClose":1.09,"halted":0,"volume":231021,"hourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.07,"latestTime":"18:15 EDT","volume":4717,"amount":4952.23,"timestamp":1713564901882},"delay":0,"floatShares":13740529,"shares":34756436,"eps":-1.280027,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"04-19 16:00:00 EDT","open":1.1,"high":1.13,"low":1.04,"amount":251431.17400169998,"amplitude":0.082569,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.280027,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"listingDate":1623988800000,"adjPreClose":1.09,"preHourTrading":{"tag":"盘前","latestPrice":1.09,"preClose":1.09,"latestTime":"09:15 EDT","volume":3600,"amount":3921.26004,"timestamp":1713532506793},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.07,"latestTime":"18:15 EDT","volume":4717,"amount":4952.23,"timestamp":1713564901882},"volumeRatio":0.37749516317354825},"requestUrl":"/m/hq/s/UNCY","defaultTab":"news","newsList":[{"id":"2422472315","title":"Unicycive Therapeutics, Inc.盘中异动 临近午盘急速拉升8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422472315","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422472315?lang=zh_cn&edition=full","pubTime":"2024-03-25 23:32","pubTimestamp":1711380736,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日23时32分,Unicycive Therapeutics, Inc.股票出现异动,股价急速上涨8.84%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Zura Bio Limited涨幅较大,Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为2856.04%、412.01%、71.59%,振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Zura Bio Limited,振幅分别为78.61%、58.38%、47.80%。Unicycive Therapeutics, Inc.公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523321687e7b85b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523321687e7b85b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419601754","title":"Unicycive Therapeutics, Inc.盘中异动 早盘急速拉升10.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419601754","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419601754?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:31","pubTimestamp":1710423062,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时31分,Unicycive Therapeutics, Inc.股票出现波动,股价快速拉升10.79%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Unicycive Therapeutics, Inc.公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体,在晚期临床前开发中已获得物质成分专利保护,用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131028781e950&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142131028781e950&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416196123","title":"Unicycive Therapeutics, Inc.盘中异动 早盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416196123","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416196123?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:47","pubTimestamp":1709567253,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时47分,Unicycive Therapeutics, Inc.股票出现波动,股价快速跳水5.50%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Unicycive Therapeutics, Inc.公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体,在晚期临床前开发中已获得物质成分专利保护,用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423473387e75b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423473387e75b57&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415320628","title":"Unicycive Therapeutics Inc盘中异动 急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415320628","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415320628?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:32","pubTimestamp":1709130736,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时32分,Unicycive Therapeutics Inc股票出现波动,股价快速跳水5.33%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.25%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体,在晚期临床前开发中已获得物质成分专利保护,用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822321687e745ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822321687e745ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414838692","title":"Unicycive Therapeutics Inc盘中异动 股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414838692","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414838692?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:39","pubTimestamp":1708958394,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时39分,Unicycive Therapeutics Inc股票出现波动,股价急速跳水5.85%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Carmell Corp、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Krystal Biotech Inc涨幅较大,Lixte Biotechnology Holdings Inc、Neubase Therapeutics Inc、Kintara Therapeutics Inc较为活跃,换手率分别为58.40%、48.63%、45.85%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Portage Biotech Inc、Sol Gel Technologies Ltd,振幅分别为29.53%、23.96%、22.60%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262239557a46ee42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262239557a46ee42&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":-0.123},{"period":"1month","weight":-0.2465},{"period":"3month","weight":0.2349},{"period":"6month","weight":0.2302},{"period":"1year","weight":-0.3354},{"period":"ytd","weight":0.2331}],"compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0486},{"period":"3month","weight":0.0264},{"period":"6month","weight":0.1756},{"period":"1year","weight":0.2022},{"period":"ytd","weight":0.0418}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。","exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}